• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较微波消融、射频、冷冻治疗和手术切除在不同肝体积治疗中的肾脏效应。

Renal effects of microwave ablation compared with radiofrequency, cryotherapy and surgical resection at different volumes of the liver treated.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Leicester Royal Infirmary, Leicester, UK.

出版信息

Liver Int. 2010 Oct;30(9):1305-14. doi: 10.1111/j.1478-3231.2010.02290.x.

DOI:10.1111/j.1478-3231.2010.02290.x
PMID:20536713
Abstract

BACKGROUND

Renal changes after microwave tissue ablation (MTA) were compared with those following hepatic resection, cryotherapy (CRYO), and radiofrequency ablation (RFA). Structural damage producing renal impairment has been assessed directly by examining tissue specimens and by serum analysis for two sensitive biomarkers, retinol binding protein (RBP) and the heat shock protein 70 (HSP-70) for each modality at different ablation volumes.

METHODS

Live rats underwent MTA, surgical resection, CRYO or RFA of 15, 33 or 66% of total hepatic volume. Urine and tissue samples were collected at the time of death. Percentage of tubules with casts and glomerular damage, tissue expression of HSP-70 and urine RBP were evaluated and compared. Behaviour of the animals was also assessed by means of five different parameters and combined to produce a response score.

RESULTS

All RFA and CRYO rats undergoing 66% died and these animals had >60% of damaged tubuli and 8% of altered glomeruli. No animals treated by MTA or surgical resection died. Cut-off values (those predicting fatal treatments) could be identified for levels of HSP-70 and RBP.

CONCLUSIONS

Large volume MTA is associated with a significant reduced renal damage and is well tolerated compared with RFA and CRYO.

摘要

背景

比较了微波组织消融(MTA)后与肝切除、冷冻疗法(CRYO)和射频消融(RFA)后肾的变化。通过检查组织标本和血清中两种敏感生物标志物(每种方式在不同消融体积下的视黄醇结合蛋白(RBP)和热休克蛋白 70(HSP-70)),直接评估了导致肾功能损害的结构损伤。

方法

活鼠接受 MTA、手术切除、15%、33%或 66%的总肝体积的 CRYO 或 RFA。在死亡时收集尿液和组织样本。评估和比较了管腔中有铸型和肾小球损伤的肾小管比例、组织中 HSP-70 的表达和尿液 RBP。还通过五个不同的参数来评估动物的行为,并将其组合成一个反应评分。

结果

所有接受 66%CRYO 和 RFA 的大鼠均死亡,这些动物有 >60%的受损肾小管和 8%的改变肾小球。接受 MTA 或手术切除的动物没有死亡。可以确定 HSP-70 和 RBP 水平的临界值(预测致命治疗的那些)。

结论

与 RFA 和 CRYO 相比,大体积 MTA 与显著降低的肾损伤相关,并且耐受性良好。

相似文献

1
Renal effects of microwave ablation compared with radiofrequency, cryotherapy and surgical resection at different volumes of the liver treated.比较微波消融、射频、冷冻治疗和手术切除在不同肝体积治疗中的肾脏效应。
Liver Int. 2010 Oct;30(9):1305-14. doi: 10.1111/j.1478-3231.2010.02290.x.
2
Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections.与射频、冷冻和手术切除相比,微波组织消融术后白细胞介素-1β和 6 的变化。
Am J Surg. 2010 Oct;200(4):500-6. doi: 10.1016/j.amjsurg.2009.12.025.
3
Large volume hepatic microwave ablation elicits fewer pulmonary changes than radiofrequency or cryotherapy.大体积肝微波消融比射频或冷冻疗法引起的肺部变化更少。
J Gastrointest Surg. 2010 Dec;14(12):1963-8. doi: 10.1007/s11605-010-1274-z. Epub 2010 Jul 30.
4
Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model.猪肝脏模型中射频消融、冷冻疗法和手术切除的全身反应比较。
Ann Surg Oncol. 2004 Jul;11(7):650-7. doi: 10.1245/ASO.2004.10.027.
5
Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.肝脏热消融:设备及加热参数对局部组织反应和远处肿瘤生长的影响
Radiology. 2016 Dec;281(3):782-792. doi: 10.1148/radiol.2016152241. Epub 2016 Jul 13.
6
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.米兰标准内小肝细胞癌的手术切除与射频消融治疗对比
J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.
7
Evidence for tumor cell spread during local hepatic ablation of colorectal liver metastases.结直肠癌肝转移局部肝切除术中肿瘤细胞播散的证据。
J Surg Res. 2012 Nov;178(1):268-79. doi: 10.1016/j.jss.2012.03.019. Epub 2012 Mar 31.
8
Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors.对接受射频消融或肝肿瘤部分肝切除术患者的全身炎症反应(SIR)评估。
Eur J Surg Oncol. 2008 Jun;34(6):662-7. doi: 10.1016/j.ejso.2007.06.009. Epub 2007 Sep 24.
9
Heat shock protein 70 expression following hepatic radiofrequency ablation is affected by adjacent vasculature.肝射频消融后热休克蛋白 70 的表达受邻近脉管的影响。
J Surg Res. 2012 Apr;173(2):249-57. doi: 10.1016/j.jss.2010.09.040. Epub 2010 Oct 23.
10
Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model.冷冻消融比射频消融或激光诱导热疗在大鼠肝模型中引起更大的炎症和凝血反应。
Surgery. 2010 May;147(5):686-95. doi: 10.1016/j.surg.2009.10.053. Epub 2009 Dec 30.

引用本文的文献

1
Comparison of local effects and systemic T-cell responses in patients with breast cancer treated by radiofrequency ablation versus microwave ablation.乳腺癌患者接受射频消融与微波消融治疗后的局部效应和全身T细胞反应比较。
Cancer Cell Int. 2025 Jul 11;25(1):261. doi: 10.1186/s12935-025-03896-7.
2
Immunomodulatory impacts of thermal and pulsed field ablation therapy on hepatocellular carcinoma associated with viral hepatitis.热消融和脉冲场消融疗法对病毒性肝炎相关肝细胞癌的免疫调节作用
Radiologie (Heidelb). 2025 Jul 10. doi: 10.1007/s00117-025-01476-4.
3
Ablation combined with video-assisted thoracic surgery hybrid technique for multiple primary lung cancer.
消融联合电视辅助胸腔镜手术杂交技术治疗多原发性肺癌
iScience. 2025 May 20;28(6):112703. doi: 10.1016/j.isci.2025.112703. eCollection 2025 Jun 20.
4
Interventional oncology and immunotherapy: current status and future perspectives.介入肿瘤学与免疫疗法:现状与未来展望
Front Immunol. 2025 Apr 8;16:1541105. doi: 10.3389/fimmu.2025.1541105. eCollection 2025.
5
Immunomodulatory effects of microwave ablation on malignant tumors.微波消融对恶性肿瘤的免疫调节作用。
Am J Cancer Res. 2024 Jun 15;14(6):2714-2730. doi: 10.62347/QJID8425. eCollection 2024.
6
Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.致敏肿瘤免疫治疗:免疫原性细胞死亡诱导纳米系统。
Int J Nanomedicine. 2024 Jun 13;19:5895-5930. doi: 10.2147/IJN.S457782. eCollection 2024.
7
tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy.经皮消融治疗的肿瘤疫苗接种及其与免疫治疗的协同作用:联合治疗的最新进展。
Front Immunol. 2023 Mar 8;14:1118845. doi: 10.3389/fimmu.2023.1118845. eCollection 2023.
8
Immunomodulatory effect of locoregional therapy in the tumor microenvironment.局部区域治疗对肿瘤微环境的免疫调节作用。
Mol Ther. 2023 Apr 5;31(4):951-969. doi: 10.1016/j.ymthe.2023.01.017. Epub 2023 Jan 24.
9
Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective.联合局部消融与免疫治疗肝细胞癌:原理、疗效与展望。
Front Immunol. 2022 Nov 23;13:1033000. doi: 10.3389/fimmu.2022.1033000. eCollection 2022.
10
Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy.消融联合免疫治疗的临床应用现状与展望。
Front Immunol. 2022 Sep 5;13:965120. doi: 10.3389/fimmu.2022.965120. eCollection 2022.